Gregory Reaman, MD, Pediatric Hematology & Oncology, Washington, DC, Washington DC Veterans Affairs Medical Center


Pediatric Hematology & Oncology Washington, DC

Associate Director Office of Hematology and Oncology Products U.S. FDA

Dr. Reaman is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Reaman's full profile

Already have an account?

Education & Training

  • Loyola University
    Loyola UniversityInternship, Transitional Year, 1973 - 1974
  • Loyola University Chicago Stritch School of Medicine
    Loyola University Chicago Stritch School of MedicineClass of 1973

Certifications & Licensure

  • VA State Medical License
    VA State Medical License 1988 - 2012
  • DC State Medical License
    DC State Medical License 1979 - 2022
  • MD State Medical License
    MD State Medical License 1977 - 2021
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • Fellow (FASCO) American Society of Clinical Oncologists, 2010

Clinical Trials

Publications & Presentations


Grant Support

  • Targeted Therapies For Childhood Acute Lymphoblastic LeukemiaNational Cancer Institute2009
  • Support For Human Specimen Banking In Nci-Supported Cancer Clinical TrialsNational Cancer Institute2007–2009
  • Children'S Oncology Group Chair'S GrantNational Cancer Institute2003–2009
  • Human Specimen Banking In Nci-Supported Cancer ClinicalNational Cancer Institute2005–2006
  • COG - Foreign AccrualNational Cancer Institute2005
  • Re-Engineering The Clinical Research EnterpriseDivision Of Epidemiology And Clinical Applications2004
  • COG Foreign AccrualNational Cancer Institute2003–2004
  • Pediatric Oncology GroupNational Cancer Institute2001–2002
  • Intergroup Rhabdomyosarcoma StudyNational Cancer Institute2001–2002
  • Childrens Cancer Group Chairmans AwardNational Cancer Institute2001–2002
  • Childrens Cancer GroupNational Cancer Institute1999–2001
  • Pediatric Phase I Trials Of Cytotoxic &Biologic AgentsNational Cancer Institute1996–2000
  • Cancer In ChildrenNational Cancer Institute1995–1998
  • Trials Of Cyotoxic And Biologic AgentsNational Cancer Institute1995
  • Pediatric Phase I Trials Of Cyotoxic &Biologic AgentsNational Cancer Institute1994
  • Cancer In ChildrenNational Cancer Institute1994
  • Pediatric Phase I Trials Of Cyotoxic And Biologic AgentsNational Cancer Institute1992–1993
  • Children'S Cancer Study GroupNational Cancer Institute1987–1993
  • Childrens Cancer Study GroupNational Cancer Institute1991
  • Anti-Gd3 Monoclonal Antibody Therapy Of T-Cell AllNational Cancer Institute1990–1991

Professional Memberships

Hospital Affiliations